Author name: Leonardo Arias

Some bosses stretch you. Others make work more bearable. Both can earn your loyalty. Only one is building your future. Leadership coach Angela Justice explains how to tell the difference.

In the current geopolitical and capital-market uncertainty, biotechs that have not mastered the basics are the ones struggling the most. Here’s how—and why—to get the details right.

As Daré Biosciences approaches a pivotal year with a key product launch ahead, the company kicked off an open public offering, providing a chance for individuals to get involved for as little as $250.

Last summer, major payers committed to pare back onerous prior authorization policies, to the skepticism of providers. Now, AHIP and the Blue Cross Blue Shield Association are providing an update on insurers’ progress.

The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European Heart Rhythm Association annual meeting in Paris.

Christian Greyenbuhl will replace Lee Westerfield, who has been interim CFO since 2023. The health IT company has worked to get up to date on its financial reporting requirements after it was delisted from the Nasdaq in 2024.

Jonathan Vigdorchik, an orthopedic surgeon from the Hospital for Special Surgery, previously was chief medical technology adviser for the company.

The acquisition of Tubulis GmbH—Gilead Sciences’ latest of the year after buying Arcells and Ouro Medicines—brings into the fold a novel ovarian cancer candidate that has demonstrated promising mid-stage data.

Regulators locked in a 2.48% rate hike for next year, much higher than the 0.09% that was proposed. Analysts said the Trump administration was likely spooked about coverage disruptions for seniors before the midterm elections.

Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie’s deal with the White House to avoid tariffs. The news comes less than a week after the president announced up to 100% levies on pharma products.